Solmeron, Adelai9da D.

HRN: 25-01-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/29/2025
09/04/2025
IV
600mg
Q8h
Infected Wound
Checking Initial Appropriateness 
08/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/29/2025
09/04/2025
IV
1.5g
Q6h
Infected Wound
Checking Initial Appropriateness 
09/06/2025
CO-AMOXICLAV 625MG (TAB)
09/06/2025
09/12/2025
ORAL
625mg
BID
Infected Wound
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: